HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$1.56
Day range
$1.49 - $1.57
Year range
$1.01 - $4.44
Market cap
107.48M USD
Avg Volume
704.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.91M | -46.42% |
Net income | -26.87M | 69.56% |
Net profit margin | — | — |
Earnings per share | -0.37 | 70.16% |
EBITDA | -34.75M | 46.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 303.43M | -28.84% |
Total assets | 351.71M | -28.47% |
Total liabilities | 77.21M | -29.23% |
Total equity | 274.50M | — |
Shares outstanding | 72.14M | — |
Price to book | 0.41 | — |
Return on assets | -23.72% | — |
Return on capital | -26.71% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.87M | 69.56% |
Cash from operations | -34.71M | 1.23% |
Cash from investing | 30.38M | -11.92% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -4.33M | -576.56% |
Free cash flow | -23.63M | -64.74% |
About
Founded
2014
Website
Employees
166
